ARV-393 is an investigational orally bioavailable PROteolysis TArgeting Chimera (PROTAC) designed to degrade B-cell lymphoma 6 protein (BCL6), a transcriptional repressor and major driver of B ...

Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting the estrogen receptor for patients with locally advanced or ...

The Close the Gap campaign is aimed at urging those defaulting on ARV treatment to return.

ARV-393 shows promising antitumor effects in combination with standard therapies for non-Hodgkin lymphoma, warranting further investigation.

Arvinas Shares New Preclinical Combination Data for the PROTAC BCL6 Degrader, ARV-393, at the 2025 American Association for Cancer Research Annual Meeting ...

The National Department of Health must finalise its planning to ensure all eligible individuals in South Africa receive a six-month supply of ARVs, with an implementation plan and timelines to be ...

Armada brings the ARV/W 106 back to its freestyle roots, softening up the flex, and adding extra pop for park skiing.

The Armada ARV/W 112 is an interesting offering in its own right, too, because, for a powder ski, it actually has a fairly small footprint, with the widest point of the tip coming in at 135mm and ...

For a freestyler looking to shred pow—and the rest of the mountain—the Armada ARV 112 is an excellent weapon of choice.

Researchers on a phase 1b/2 trial dosed their first patient with samuraciclib and ARV-471, a novel treatment regimen for patients with a breast cancer subset.

This image of the spiral galaxy M51 has been named the top James Webb Space Telescope image of 2023 by the public. A World Cup-style knockout poll on the Webb Telescope Twitter feed produced the ...